Jakub Svoboda | BiotechTV

top of page

Penn Medicine's Jakub Svoboda describes a CD19 CAR-T that has been armored with IL18 and is being studied for CAR-T relapse patients

May 2, 2024

Bright Minds

Penn Medicine's Jakub Svoboda describes a CD19 CAR-T that has been armored with IL18 and is being studied for CAR-T relapse patients

He will be presenting final data from a 21 patient NHL cohort at the 2024 ASCO Annual Meeting in June.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Saville's Life Sciences Overview